• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
Morning Session:
 
FDA
 
FDA Presentations, Semuloparin Sodium Injection, for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 437KB)
 
 
Sanofi-aventis U.S. LLC.
 
Sanofi-aventis Presentations, Semuloparin Sodium Injection, for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 2.45MB)
 
 
Afternoon Session:
 
FDA
 
FDA Presentations, Kyprolis (Carfilzomib) for Injection, for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 192KB)
 
 
Onyx Pharmaceuticals, Inc.
 
Onyx Presentations, Kyprolis (Carfilzomib) for Injection, for the June 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 983KB)